SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-326001
Filing Date
2020-12-23
Accepted
2020-12-23 16:15:54
Documents
12
Period of Report
2020-12-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d18306d8k.htm   iXBRL 8-K 25792
  Complete submission text file 0001193125-20-326001.txt   149298

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mgta-20201222.xsd EX-101.SCH 3073
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20201222_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20201222_pre.xml EX-101.PRE 11407
5 EXTRACTED XBRL INSTANCE DOCUMENT d18306d8k_htm.xml XML 3347
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 201412412
SIC: 2834 Pharmaceutical Preparations